Table 3.

Multivariable association of an episode of AKI and change (fold increase) in level of urine protein-to-creatinine ratio overall and analyses that exclude receipt of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or systolic BP level

ComparisonsFull Model (Shown in Supplemental Table 2)Model Excluding Receipt of ACE-I/ARBModel Excluding Systolic BP Level
Relative Risk (95% CI)P ValueRelative Risk (95% CI)P ValueRelative Risk (95% CI)P Value
AKI between study visits (versus no AKI)1.09 (1.02 to 1.16)0.011.09 (1.02 to 1.17)0.011.07 (1.00 to 1.14)0.04
  • ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; 95% CI, 95% confidence interval.